SUPN Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Supernus Pharmaceuticals Inc

Watchlist Manager

Watchlist

Price: 52.195 USD 1.45%

Market Cap: $3B

	Supernus Pharmaceuticals Inc NASDAQ:SUPN	US
	Credicorp Ltd NYSE:BAP	PE
	Comstock Inc F:GSP	US
A	Arribatec Group ASA F:B7Z	NO
	Heidelberg Pharma AG XETRA:HPHA	DE
	Bureau Veritas SA PAR:BVI	FR
C	Cadence Design Systems Inc F:CDS	US
N	NovaBay Pharmaceuticals Inc AMEX:NBY	US
A	Amper SA XMUN:APR	ES
	Juventus FC SpA MIL:JUVE	IT
	Chocoladefabriken Lindt & Spruengli AG OTC:LDSVF	CH

Profitability Summary

Supernus Pharmaceuticals Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

90%

Strong 3Y Average Gross Margin

88%

Gross Margin is Increasing

86% > 90%

Low Operating Margin

Low 3Y Average Operating Margin

Declining Operating Margin

7% > 2%

Negative Net Margin

-5%

Low 3Y Average Net Margin

Declining Net Margin

8% > -5%

Healthy Free Cash Flow Margin

Strong 3Y Average Free Cash Flow Margin

19%

Declining Free Cash Flow Margin

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.